Clinical trial
Prospective Evaluation of OptiThyDose, a Mathematical Model for Calculating Appropriate Dose Ranges in Children With Thyroid Diseases
NCT06864351 is registered in ClinicalTrials.gov with University Children's Hospital Basel as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of OptiThyDose, a Mathematical Model for Calculating Appropriate Dose Ranges in Children With Thyroid Diseases
- Lead sponsor
- University Children's Hospital Basel
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 28, 2025
- Completion date
- February 28, 2029
- Enrollment
- 150 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.